-
-
-
F156757-1gNatural flavonoid with a variety of biological effects.
-
F156757-25gNatural flavonoid with a variety of biological effects.
-
F156757-50gNatural flavonoid with a variety of biological effects.
-
F156757-5gNatural flavonoid with a variety of biological effects.
-
F124946-100mgFlavopiridol competes with ATP to inhibit CDKs including CDK1, CDK2, CDK4 and CDK6 with IC50 of ~ 40 nM. It is 7.5-fold more selective for CDK1/2/4/6 than CDK7. Flavopiridol is initially found to inhibit EGFR and PKAA synthetic flavonoid derivative,
-
F124946-1mgFlavopiridol competes with ATP to inhibit CDKs including CDK1, CDK2, CDK4 and CDK6 with IC50 of ~ 40 nM. It is 7.5-fold more selective for CDK1/2/4/6 than CDK7. Flavopiridol is initially found to inhibit EGFR and PKAA synthetic flavonoid derivative,
-
F124946-250mgFlavopiridol competes with ATP to inhibit CDKs including CDK1, CDK2, CDK4 and CDK6 with IC50 of ~ 40 nM. It is 7.5-fold more selective for CDK1/2/4/6 than CDK7. Flavopiridol is initially found to inhibit EGFR and PKAA synthetic flavonoid derivative,
-
F124946-25mgFlavopiridol competes with ATP to inhibit CDKs including CDK1, CDK2, CDK4 and CDK6 with IC50 of ~ 40 nM. It is 7.5-fold more selective for CDK1/2/4/6 than CDK7. Flavopiridol is initially found to inhibit EGFR and PKAA synthetic flavonoid derivative,
-
F124946-5mgFlavopiridol competes with ATP to inhibit CDKs including CDK1, CDK2, CDK4 and CDK6 with IC50 of ~ 40 nM. It is 7.5-fold more selective for CDK1/2/4/6 than CDK7. Flavopiridol is initially found to inhibit EGFR and PKAA synthetic flavonoid derivative,
-